Back
Fulcrum Therapeutics 10K Form
Sell
40
FULC
Fulcrum Therapeutics
Last Price:
3.45
Seasonality Move:
85.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FULC News And Ratings
See the #1 stock for the next 7 days that we like better than FULC
FULC Financial Statistics
Sales & Book Value
| Annual Sales: | $2.81M |
|---|---|
| Cash Flow: | $58.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.40 |
| Price / Book: | 0.76 |
Profitability
| EPS (TTM): | -0.35000 |
|---|---|
| Net Income (TTM): | $-20.23M |
| Gross Margin: | -- |
| Return on Equity: | -8.07% |
| Return on Assets: | -7.42% |
Fulcrum Therapeutics Earnings Forecast
Key Fulcrum Therapeutics Financial Ratios
- The Research & Development expenses have been 2,559.75% of Revenue.
- The Net Earning history of FULC is -3,470.05% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 4 years.
Fulcrum Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | FULC |
| CUSIP: | 359616 |
| Website: | fulcrumtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 22.07 |
| Quick Ratio: | 21.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
FULC Technical Analysis vs Fundamental Analysis
Sell
40
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a Sell
The current Fulcrum Therapeutics [FULC] share price is $3.44. The Score for FULC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.